Brokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospects and expansion plans. Despite near-term challenges like pricing pressure and rising costs, analysts are backing companies with robust margin profiles and clear growth visibility. Key recommendations include Sun Pharma, Eicher Motors, and Max Healthcare Institute.